Trials / Terminated
TerminatedNCT00967447
Study to Evaluate the Safety and Efficacy of Pradaxar for the Prevention of Venous Thromboembolism in the Mexican Population Undergoing Elective Total Hip or Knee Replacement Surgery
Incidence of Symptomatic Venous Thromboembolic Events and Major Bleeding Events After Dabigatran Etexilate in Patients Subject to Subject to Elective Total Hip or Knee Replacement Surgery.
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 2 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 18 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
Open, prospective, uncontrolled, observational cohort study.
Conditions
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2010-01-01
- First posted
- 2009-08-27
- Last updated
- 2025-02-11
- Results posted
- 2012-04-05
Locations
28 sites across 1 country: Mexico
Source: ClinicalTrials.gov record NCT00967447. Inclusion in this directory is not an endorsement.